Clinical trial
Perioperative Infusion of Dexmedetomidine Improves Outcomes of Cardiovascular Surgery
NCT02237495 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Infusion of Dexmedetomidine Improves Outcomes of Cardiovascular Surgery
- Lead sponsor
- Xijing Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 9, 2014
- Completion date
- March 31, 2018
- Enrollment
- 1,100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.